Abstract:Abstract Background Cells have evolved balanced mechanisms to protect themselves by initiating a specific response to a variety of stress. The TP53 gene, encoding P53 protein, is one of the many widely studied genes in human cells owing to its multifaceted functions and complex dynamics. The tumour-suppressing activity of P53 plays a principal role in the cellular response to stress. The majority of the human cancer cells exhibit the inactivation of the P53 pathway. In this review, we discuss the recent advancements in P53 research with particular focus on the role of P53 in DNA damage responses, apoptosis, autophagy, and cellular metabolism. We also discussed important P53-reactivation strategies that can play a crucial role in cancer therapy and the role of P53 in various diseases. Main body We used electronic databases like PubMed and Google Scholar for literature search. In response to a variety of cellular stress such as genotoxic stress, ischemic stress, oncogenic expression, P53 acts as a sensor, and suppresses tumour development by promoting cell death or permanent inhibition of cell proliferation. It controls several genes that play a role in the arrest of the cell cycle, cellular senescence, DNA repair system, and apoptosis. P53 plays a crucial role in supporting DNA repair by arresting the cell cycle to purchase time for the repair system to restore genome stability. Apoptosis is essential for maintaining tissue homeostasis and tumour suppression. P53 can induce apoptosis in a genetically unstable cell by interacting with many pro-apoptotic and anti-apoptotic factors. Furthermore, P53 can activate autophagy, which also plays a role in tumour suppression. P53 also regulates many metabolic pathways of glucose, lipid, and amino acid metabolism. Thus under mild metabolic stress, P53 contributes to the cell’s ability to adapt to and survive the stress. Conclusion These multiple levels of regulation enable P53 to perform diversified roles in many cell responses. Understanding the complete function of P53 is still a work in progress because of the inherent complexity involved in between P53 and its target proteins. Further research is required to unravel the mystery of this Guardian of the genome “ TP53 ”.

How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?

Live or let die: the cell's response to p53

p53: 800 million years of evolution and 40 years of discovery

p53's Multifaceted Role in the DNA Damage Response and Tumor Treatment Strategies

An overview of the functions of p53 and drugs acting either on wild- or mutant-type p53

Targeting p53 pathways: mechanisms, structures, and advances in therapy

TP53 mutations in cancer: Molecular features and therapeutic opportunities (Review)

Elucidating the chain of command: our current understanding of critical target genes for p53-mediated tumor suppression

Translating p53-based therapies for cancer into the clinic

At a Crossroads to Cancer: How p53-Induced Cell Fate Decisions Secure Genome Integrity

Of the many cellular responses activated by TP53, which ones are critical for tumour suppression?

p53, cancer and the immune response

DNA repair processes are critical mediators of p53-dependent tumor suppression

Small Molecule Agents Targeting the P53-Mdm2 Pathway for Cancer Therapy

The multiple mechanisms that regulate p53 activity and cell fate

Progress and Prospects: Roles of P53 in Tumor Development

A Different Facet of p53 Function: Regulation of Immunity and Inflammation During Tumor Development

p53 signaling in cancer progression and therapy

Exploring the multiple roles of guardian of the genome: P53

Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy

Tumor Suppressor P53 and Its Gain-of-function Mutants in Cancer